Illustrative image – not actual.
The Central government is considering establishing three or four pharma parks for manufacturing active pharmaceutical ingredients (API).
It is planning to set up bulk drugs manufacturing hubs as part of its strategy to reduce the country's dependence on Chinese inputs for its export-intensive pharmaceuticals industry.
Each manufacturing park is estimated to cost about Rs 200 crore, and Andhra Pradesh and Telangana are interested in offering land for the purpose.
However, the plan to set up API parks faces one major hurdle of clearance from the environment ministry since APIs are highly polluting.
